|
|
|
|
|
by jonahhorowitz
326 days ago
|
|
As long as they spend so much on marketing, it's hard to believe them when they say the only way they can recoup their R&D investments is to charge high prices. - *For many large pharmaceutical companies ("Big Pharma"), marketing costs often exceed R&D spending.* In analyses of the top 10 drugmakers by revenue in 2020, 7 companies spent more on sales and marketing than on research and development. For example, Johnson & Johnson spent $22 billion on marketing compared to $12 billion on R&D; Bayer spent $18 billion on marketing vs. $8 billion on R&D[1][2]. - The combined marketing spend for these top 10 companies exceeded R&D by $36 billion (about 37%) in 2020[1][2]. [1] https://www.ahip.org/news/articles/new-study-in-the-midst-of...
[2] https://www.csrxp.org/icymi-new-study-finds-big-pharma-spent... |
|
Surely that's something that would be easier to get bipartisan support for, somewhat avoiding the "socialism vs capitalism" chasm between the parties that prevents meaningful healthcare reform.